Predictors of multidomain decline in health-related quality of life after stereotactic body radiation therapy (SBRT) for prostate cancer.
Robert T DessWilliam C JacksonSimeng SuyPayal D SoniJae Y LeeAhmed E AbugharibZachary S ZumstegFelix Y FengDaniel A HamstraSean P CollinsDaniel E SprattPublished in: Cancer (2016)
Prostate SBRT has minimal long-term impact on multidomain decline, and the majority of more significant multidomain declines appear to be unrelated to treatment. This emphasizes the importance of focusing not only on the side effects of prostate cancer treatment but also on other comorbid illnesses that contribute to overall HRQOL. Cancer 2017;123:1635-1642. © 2017 American Cancer Society.